Cardica (NASDAQ: CRDC)

Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to reduce operating time and facilitate minimally-invasive and robot-assisted surgeries. Cardica's MicroCutter XCHANGE™ 30, a cartridge-based surgical stapling device with a five-millimeter shaft diameter, is manufactured and cleared for use in a variety of gastrointestinal procedures and appendectomies in the United States, and is marketed for a wide range of surgical procedures in Europe. Cardica is developing the Cardica® MicroCutter XCHANGE™ 45, a cartridge-based microcutter device with an eight-millimeter shaft to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter XCHANGE 45 product requires 510(k) review and CE Mark and is not yet commercially available in the U.S. or internationally. In addition, Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 49,000 units throughout the world.

Find a broker to begin trading CRDC now

Company Name Cardica
Market/Symbol NASDAQ: CRDC
Recent Price
Market Cap $22.34M
Avg. Daily Vol. (3m) 49,677
Price/Book N/A
Price/Cash Flow 79x
As of Jun. 21, 2016
*Source: QuoteMedia

Begin trading CRDC

 Find Broker

Recent Company Videos

Cardica (NASDAQ: CRDC) Developing Proprietary Tech for Surgical Procedures

May. 1, 2013

Dr. Bernard Hausen, CEO of Cardica (NasdaqGM: CRDC), discusses the company at the RedChip Emerging Growth Showcase. Cardica designs and ...

Cardica Latest News

Ask the CEO

Meet The Board of Directors

Kevin T. Larkin

Chairman of the Board Cardica, Inc. and President and Chief Executive Officer TherOx, Inc.

Bernard A. Hausen

President, Chief Executive Officer and Co-founder Cardica, Inc.

Richard P. Powers

Executive Vice President VisionCare Opthalmic Technologies, Inc.

Jeffrey L. Purvin

Chief Executive Officer Response Biomedical Corporation

John Simon

Managing Director Allen & Company LLC

William H. Younger, Jr.

Managing Director Sutter Hill Ventures

Meet The Management Team

Bernard A. Hausen

President, Chief Executive Officer & Co-Founder

Frederick Bauer

Vice President, Manufacturing & Operations

Liam Burns

Vice President, Sales and Marketing

Bryan D. Knodel

Vice President Research & Development

Robert Y. Newell

Chief Financial Officer & Vice President, Finance

RedChip Direct Investment Opportunities For Private and Public Companies

Receive CRDC Email Alerts

*By entering your information you agree to our privacy policy.

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President The NASDAQ Stock Market